Herb-drug interactions: St. John's wort and prescription medications

Geriatrics

Volumn 60, Issue 7, 2005, Pages 21-23

  Bressler, Rubin ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CYCLOSPORIN; DIGOXIN; ECHINACEA EXTRACT; FEXOFENADINE; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HERBACEOUS AGENT; HYPERFORIN; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; IMMUNOSUPPRESSIVE AGENT; KAVA EXTRACT; MIDAZOLAM; NEFAZODONE; NIFEDIPINE; NORTRIPTYLINE; PAROXETINE; QUAZEPAM; SABAL EXTRACT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SIMVASTATIN; TACROLIMUS; THEOPHYLLINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; WARFARIN;

AGED; ALTERNATIVE MEDICINE; ANXIETY DISORDER; CHRONIC DISEASE; DEPRESSION; DIZZINESS; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG INFORMATION; DRUG MECHANISM; DRUG METABOLISM; ENZYME INDUCTION; FATIGUE; GASTROINTESTINAL SYMPTOM; GERIATRIC PATIENT; GERONTOPSYCHIATRY; HERB DRUG INTERACTION; HERBAL MEDICINE; HUMAN; INTERNET; MALE INFERTILITY; MENTAL DISEASE; PATIENT EDUCATION; PHOTOSENSITIVITY DISORDER; POLYPHARMACY; PRESCRIPTION; PSYCHOPHARMACOTHERAPY; RASH; REVIEW; SEROTONIN SYNDROME; XEROSTOMIA;

COMPLEMENTARY THERAPIES; DRUG INTERACTIONS; HUMANS; HYPERICUM; PHYTOTHERAPY; PLANT PREPARATIONS;

EID: 22544450472     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Ang-Lee MK, Moss MK, Yuan CS. Herbal medicines and perioperative care. JAMA 2001; 286(2):208-16.
2. Ernst E, Pittler MH. Herbal medicine. Med Clin North Am 2002; 86(1):149-61.
3. Astin, JA. Why patients use alternative medicine: Results of a national study. JAMA 1998; 279(19):1548-53.
4. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993; 328(4)246-52.
5. Bressler R, Bahl JJ. Principles of drug therapy for the elderly patient. Mayo Clin Proc 2003; 78(12):1564-77.
6. Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med 2002; 136(1):42-53.
7. Miller LG. Herbal medicinals: Selected clinical considerations focusing on klnown or potential drug-herb interactions. Arch Intern Med 1998; 158(20):2200-11.
8. David S. Tatro, ed. Drug Interaction Facts: Herbal Supplements and Food. Saint Louis, MO; Facts and Comparisons, A. Walters Kluwer Company; 2004. Also available online at: www.factsand comparisons.com.
9. Phillip M, Kohnen R, Hiller KO. Hypericum extract versus impramine or placebo in patients with moderate depression: Randomized multicenter study of treatment for eight weeks. BMJ 1999; 319(7224):1534-8.
10. Stevinson C, Ernst E. Hypericum for depresion. An update of the clinical Evidence. Eur Psychopharmacol 1999; 9(6):501-5.
11. Gaster B, Holroyd J. St. John's wort for depression: A systemic review. Arch Intern Med 2000; 160(2):152-6.
12. Szegedi A, Kohnen R, Dienel A, Kieser M. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): Randomised controlled double blind non-inferiority trial versus paroxetine. BMJ [serial online] February 11, 2005:1-5.
13. Neary JT, Bu Y. Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes. Brain Res 1999; 816(2):358-63.
14. Wagner H, Bladt S. Pharmaceutical quality of hypericum extracts. J Geriatr. Psychiatry Neurol 1994; 7(suppl 1):S65-8.
15. Muller WE, Singer A, Wonnermann M, Hafner U, Rolli M, Schafer C. Hyperforin represents the neurotransmitters reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry 1998; 31(suppl 1):16-21.
16. Franklin M, Chi J, McGavin C, et al. Neuroendocrine evidence for dopaminergic actions of hypericum extract (LI 160) in healthy volunteers. Biol Psychiatry 1999; 46(4):581-4.
17. nd ed. Washington, DC: American Psychiatric Publishing; 2003:11-40.